Pacific Biosciences of California, Inc. (PACB)

13.90
NASDAQ
Prev Close 13.78
Day Low/High 13.33 / 13.91
52 Wk Low/High 2.20 / 15.12
Exchange NASDAQ
Shares Outstanding 176.66B
Market Cap 2.43B
P/E Ratio N/A
Div & Yield N.A. (N.A)
Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

The Menlo Park, Calif.-based firm had a third-quarter net loss of $22 million, compared with $17.5 million in the year-ago period. Product, service and other revenue rose 9% year-over-year to $23.5 million.

Illumina Shares Hammered by Sales Forecast Cut

Illumina Shares Hammered by Sales Forecast Cut

Cantor Fitzgerald says Illumina's outlook revision is not likely to affect industry peers.

This Bounce Could Keep Going

Despite the tepid open, I'm participating with a position in SSO and PACB's chart still looks good.

Stick To Index and Large-Cap Plays

The gap-up open quickly faded, and there is no buying traction at all, right now.

Rev Forum: Make the Market Prove Itself

A strong open doesn't always produce greater clarity.

Tough to Find Individual Stocks I Like

Indices are the way so far in today's challenging market.

You Can't Blame It All on the Fed

There are a number of forces at play in market carnage.

Illumina Dims, but It's Still Set Up to Shine

With such a commanding lead in the sequencing business the stock can't stay down for long.

Budget, Fannie-Freddie Reform Could Boost Defense, Medical, Housing

Budget, Fannie-Freddie Reform Could Boost Defense, Medical, Housing

Washington will offer mixed bag answers to key policy questions.

Opening Up My Watch List

Opening Up My Watch List

Four small-caps I have an eye on.

The Market Caved

The Market Caved

But how long will it last?